Citicoline as Neuroprotector in Preterm
ConditionPre-Term
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
AgeUp to 1
SponsorSherief Abd-Elsalam
About this trial
Citicoline as neuroprotector in preterm
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Preterm on CPAP or ventilator
Disqualifiers
Multiple congenital anomalies
Trial design
Design model
Parallel
Treatments tested in this trial
Citicoline
DrugCiticoline as neuroprotector
Placebo oral tablet
Drugplacebo drug
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: CiticolineExperimental treatment 1 intervention
Group B: Placebo drugPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Number of children with affection of the brain
Number of children with affection of the brain
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Sherief Abd-Elsalam
Lead sponsor
Tanta University
Sponsor institution
Source ClinicalTrials.gov